ACTIVATING EFFECT OF THE FLAVONOID PHLORETIN ON CA2+-ACTIVATED K+ CHANNELS IN MYELINATED NERVE-FIBERS OF XENOPUS-LAEVIS (VOL 165, PG 167, 1994)

被引：0

|

作者：

KOH, DS

REID, G

VOGEL, W

机构：

来源：

NEUROSCIENCE LETTERS | 1994年 / 170卷 / 01期

关键词：

D O I：

暂无

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

引用

收藏

页码：198 / 198

页数：1

相关论文

共 7 条

[1] EFFECT OF THE FLAVOID PHLORETIN ON CA2+-ACTIVATED K+ CHANNELS IN MYELINATED NERVE-FIBERS OF XENOPUS-LAEVIS
KOH, DS
REID, G
VOGEL, W
NEUROSCIENCE LETTERS, 1994, 165 (1-2) : 167 - 170
[2] Xenopus laevis oocytes contain endogenous large conductance Ca2+-activated K+ channels
Krause, JD
Foster, CD
Reinhart, PH
NEUROPHARMACOLOGY, 1996, 35 (07) : 1017 - 1022
[3] Carbon monoxide dilates cerebral arterioles by enhancing the coupling of Ca2+ sparks to Ca2+-Activated K+ channels (vol 91, pg 610, 2002)
Jaggar
CIRCULATION RESEARCH, 2002, 91 (10) : E34 - E34
[4] Ketamine block Ca2+-activated K+ channels in rabbit cerebral arterial smooth muscle cells (vol 285, pg H1347, 2003)
Han, H
Kim, N
Joo, H
Kim, E
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2003, 285 (05): : H2251 - H2251
[5] Partial apamin sensitivity of human small conductance Ca2+-activated K+ channels stably expressed in Chinese hamster ovary cells (vol 366, pg 470, 2002)
Dale, TJ
Cryan, JE
Chen, MX
Trezise, DJ
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2003, 367 (01) : 86 - 86
[6] Ca2+-activated K+ channels modulate basal and E2β-induced rises in uterine blood flow in ovine pregnancy (vol 50, pg H422, 2001)
Rosenfeld, CR
Cornfield, DN
Roy, T
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2001, 281 (03):
[7] Effect of 4-(5-chloro-2-hydroxyphenyl)-3-(2-hydroxyethyl)-6-(trifluoromethyl)-quinolin-2(1H)-one (BMS-223131), a novel opener of large conductance Ca2+ activated K+ (maxi-K) channels on normal and stress-aggravated colonic motility and visceral nociception (vol 313, pg 840, 2005)
Sivarao, DV
Newberry, K
Langdon, S
Lee, AV
Hewawasam, P
Plym, MJ
Signor, L
Myers, R
Lodge, NJ
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 315 (01): : 476 - 476